1. Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion
   Xin Li et al, 2023, Protein & Peptide Letters CrossRef
2. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
   Yaru Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
   Mina Alimohammadi et al, 2023, Current Pharmaceutical Design CrossRef
4. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling
   Zhaohui Zhu et al, 2024, Clinical Breast Cancer CrossRef
5. Endoplasmic reticulum-targeted NIR-II phototherapy combined with inflammatory vascular suppression elicits a synergistic effect against TNBC
   Guoyun Wan et al, 2023, Biomaterials Science CrossRef
6. PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters
   Olga Stanowska et al, 2022, Journal of Clinical Medicine CrossRef
7. Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer
   Lea Ling-Yu Kan et al, 2023, Molecules CrossRef
8. Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles
   Wen Zhang et al, 2024, Acta Pharmaceutica Sinica B CrossRef
9. Comparison of immunotherapy with chemotherapy on triple-negative breast cancer
   Ruiting Zhou et al, 2023, International Conference on Modern Medicine and Global Health (ICMMGH 2023) CrossRef